Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CARHSP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPS9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EEF1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00514 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GSK3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6734 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OAZ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ILF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBA1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL13AP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FARSA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAPDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CIZ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on